Published in J Allergy Clin Immunol on April 01, 2000
Role of viral respiratory infections in asthma and asthma exacerbations. Lancet (2010) 2.60
Early identification of atopy in the prediction of persistent asthma in children. Lancet (2008) 2.27
The ABCs of rhinoviruses, wheezing, and asthma. J Virol (2010) 1.89
Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy (2009) 1.87
The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc (2009) 1.40
Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol (2008) 1.14
Rhinoviruses, allergic inflammation, and asthma. Immunol Rev (2011) 0.99
Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc Am Thorac Soc (2007) 0.97
Rhinovirus-Induced Exacerbations of Asthma and COPD. Scientifica (Cairo) (2013) 0.97
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog (2013) 0.96
Asthma exacerbations. 2: aetiology. Thorax (2006) 0.94
Molecular epidemiology of respiratory viruses in virus-induced asthma. Front Microbiol (2013) 0.93
Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study. Respir Res (2009) 0.92
Virus/allergen interactions and exacerbations of asthma. Immunol Allergy Clin North Am (2010) 0.91
Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features. Clin Transl Allergy (2012) 0.87
Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One (2011) 0.85
Adaptive immunity to rhinoviruses: sex and age matter. Respir Res (2010) 0.84
Viral respiratory infection and the link to asthma. Pediatr Infect Dis J (2008) 0.84
The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. Rev Med Virol (2014) 0.82
Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection. J Med Virol (2014) 0.79
Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model. PLoS One (2014) 0.78
The infectious march: the complex interaction between microbes and the immune system in asthma. Immunol Allergy Clin North Am (2010) 0.77
Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans. J Immunol (2016) 0.75
Asthma and pregnancy: do they give clues to abnormal antiviral activity? Thorax (2011) 0.75
Viral Infections and Associated Factors That Promote Acute Exacerbations of Asthma. Allergy Asthma Immunol Res (2018) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med (1986) 4.99
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med (1998) 2.96
Effects of dog ownership in early childhood on immune development and atopic diseases. Clin Exp Allergy (2008) 2.86
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51
Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J (2008) 2.46
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med (2000) 2.29
Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol (2009) 2.22
Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2000) 2.18
Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J (2010) 2.15
An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol (1999) 1.77
Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med (1997) 1.72
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol (1992) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Evolution of dry powder inhaler design, formulation, and performance. Respir Med (2002) 1.55
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Chest (1999) 1.51
Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med (2001) 1.46
Enhanced thrombolysis, reduced coronary reocclusion and limitation of infarct size with liposomal prostaglandin E1 in a canine thrombolysis model. J Am Coll Cardiol (1994) 1.39
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Safe administration of influenza vaccine to patients with egg allergy. J Pediatr (1998) 1.34
Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol (1998) 1.33
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis (1992) 1.33
Peanut oil is not allergenic to peanut-sensitive individuals. J Allergy Clin Immunol (1981) 1.32
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol (2001) 1.32
Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med (1998) 1.30
Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J Biol Chem (1994) 1.30
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. Science (1976) 1.27
In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis (1985) 1.27
Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells. J Gen Virol (2004) 1.26
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20
Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med (1978) 1.18
Early life origins of asthma. J Clin Invest (1999) 1.17
Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol (2000) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med (1996) 1.15
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med (1995) 1.14
The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol (2000) 1.14
Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy (2010) 1.14
Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol (1996) 1.13
Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents across the school year. J Interferon Cytokine Res (1997) 1.12
Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am Rev Respir Dis (1977) 1.12
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med (1997) 1.11
The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med (1998) 1.11
Long-term benzodiazepine therapy: benefits and risks. Psychopharmacol Bull (1984) 1.11
The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med (1997) 1.11
The role of viral infections in the natural history of asthma. J Allergy Clin Immunol (2000) 1.09
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med (1995) 1.09
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
The role of respiratory viruses in acute and chronic asthma. Clin Chest Med (2000) 1.08
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis (1993) 1.08
Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy (2006) 1.07
Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol (1996) 1.07
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol (2000) 1.06
Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol (1998) 1.05
Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol (1995) 1.04
Instability of aqueous captopril solutions. Am J Hosp Pharm (1993) 1.04
Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol (1998) 1.04
Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest (1981) 1.03
Methods and prevalence of ADL limitations in Hispanic and non-Hispanic white subjects in rural Colorado: the San Luis Valley Health and Aging Study. Ann Epidemiol (1999) 1.03
Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03
Asthma. JAMA (1997) 1.02
Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol (1988) 1.01
Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol (1985) 1.00
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods (1996) 0.99
Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy (2013) 0.99
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respir Med (2009) 0.98
Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis (1993) 0.98
Retinoids as ligands and coactivators of protein kinase C alpha. FASEB J (2000) 0.97
Viruses in asthma. J Allergy Clin Immunol (1997) 0.97
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol (1999) 0.97
Decreased H2 histamine response of granulocytes of asthmatic patients. J Clin Invest (1977) 0.97
Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med (1997) 0.96
The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis (1989) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Isoproterenol inhibition of isolated human neutrophil function. J Allergy Clin Immunol (1984) 0.95
Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy (2003) 0.95
Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Circulation (1995) 0.95
Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis (1990) 0.94
Asthma exacerbations. 2: aetiology. Thorax (2006) 0.94